![Allergy therapeutics plc](https://directorstalk.net/wp-content/uploads/2015/10/Allergy-therapeutics-plc.png)
Allergy Therapeutics Plc Successful litigation settlement of $7.6 million
Commenting on outcome, Manuel Llobet, CEO of Allergy Therapeutics, said: “ATL has always had full confidence in the Grass MATA MPL product and maintained that the inconclusive results of the G204 study